Commerzbank AG (OTCPK:CRZBF) Q3 2024 Earnings Conference Call November 6, 2024 3:00 AM ET Company Participants Bettina Orlopp - Chief Executive Officer, Chief Financial Officer and Chairwoman Conference Call Participants Benjamin Goy - Deutsche Bank Kian Abouhossein - JPMorgan Tobias Lukesch - Kepler Cheuvreux Borja Ramirez - Citi Jeremy Sigee - BNP Paribas Mate Nemes - UBS Riccardo Rovere - Mediobanca Krishnendra Dubey - Barclays Anke Reingen - RBC Chris Hallam - Goldman Sachs Operator Hello and welcome to ...

Financial Data and Key Metrics - Net sales for Q3 2024 were approximately $3 million, a decrease from $3.3 million in the same period last year, driven by lower instrument sales [22] - Gross margin improved to 29% in Q3 2024, up from 3% in the prior year, due to product mix and an inventory write-down in the previous period [24] - Selling, general, and administrative (SG&A) expenses decreased to $5.6 million from $7.8 million, primarily due to lower employee-related expenses [25] - Research and development (R&D) expenses declined to $3.8 million from $7 million, driven by reduced third-party development costs for the WAVE program [26] - Net loss for the quarter was $14.6 million, resulting in a loss per share of $0.59 [27] - Cash used in the quarter was $5.5 million, with a target cash burn rate of $5 million per quarter [27][40] Business Line Updates - The WAVE system's clinical trial for Gram-Negative testing is on track, with external site enrollments meeting expectations and strong reliability demonstrated [7] - FDA 510(k) clearance was obtained for the Accelerate Arc system, which automates microbial identification from positive blood cultures, reducing diagnostic turnaround times [9][10] - The company is focusing on converting its existing Pheno customers to WAVE, with ongoing education and long-term contracts in place [32][33] - The Arc system is expected to complement WAVE by automating MALDI-based rapid ID workflows, with high customer receptivity [15][36] Market and Strategic Direction - The company is strengthening its leadership in the rapid positive blood culture AST market and disrupting the isolate susceptibility testing landscape, which is a $1 billion market [11][18] - WAVE is positioned to consolidate lab testing volumes on a single platform, addressing customer demand for unified AST solutions [17] - Future plans include expanding WAVE to new markets and exploring applications of holographic imaging technology in other diagnostic fields [19] Management Commentary on Operating Environment and Outlook - Management is encouraged by the progress in the WAVE clinical trial and the commercial launch of Arc, with growing market interest in WAVE [20] - The company anticipates having sufficient operating cash through year-end 2025, contingent on receiving contractual payments from third-party partnerships [28] - Management emphasized disciplined financial management to maintain market leadership and support future innovation [44] Q&A Session Question: Transition from Pheno to WAVE - The company has a plan in place to transition existing Pheno customers to WAVE, with ongoing education and long-term contracts. The majority of Pheno customers are expected to convert to WAVE post-launch [31][32][33] Question: Commercial Roadmap for Arc - The Arc system has been well-received, with high customer interest. The sales force is trained, and marketing plans are in place, but it is too early to provide financial guidance for 2025 [35][36][37] Question: Cash Usage Outlook - The company is targeting a cash burn rate of $5 million per quarter, with strong working capital gains in Q3 2024. Future cash usage will focus on delivering key milestones while maintaining financial discipline [39][40][41]

Twin Disc, Incorporated (NASDAQ:TWIN) Q1 2025 Results Earnings Conference Call November 6, 2024 9:00 AM ET Company Participants Jeffrey Knutson - Vice President of Finance, Chief Financial Officer, Treasurer and Secretary John Batten - Chief Executive Officer Conference Call Participants Simon Wong - Gabelli Funds Operator Thank you for standing by. My name is Andrea, and I will be your conference operator today. At this time, I would like to welcome everyone to the Twin Disc, Incorporated Fiscal First Quar ...

AMC Networks Inc. (NASDAQ:AMCX) Q3 2024 Earnings Conference Call November 8, 2024 10:00 AM ET Company Participants Nicholas Seibert - Vice President of Corporate Development & Investor Relations Kristin Dolan - Chief Executive Officer Patrick O'Connell - Chief Financial Officer Kim Kelleher - Chief Commercial Officer Dan McDermott - President of Entertainment and AMC Studios Conference Call Participants Thomas Yeh - Morgan Stanley Steven Cahall - Wells Fargo David Joyce - Seaport Research Partners Charles W ...

ADTRAN Holdings, Inc. (NASDAQ:ADTN) Q3 2024 Earnings Conference Call November 7, 2024 10:30 AM ET Corporate Participants Tom Stanton - Chief Executive Officer Uli Dopfer - Chief Financial Officer Conference Call Participants George Notter - Jefferies Michael Genovese - Rosenblatt Securities Tim Savageaux - Northland Capital Markets Bill Dezellem - Teiton Capital Ryan Koontz - Needham & Company Operator Ladies and gentlemen, thank you for standing by and welcome to the ADTRAN Holdings Incorporated Third Quar ...

The Eastern Company (NASDAQ:EML) Q3 2024 Earnings Call Transcript November 6, 2024 11:00 AM ET Company Participants Marianne Barr - Treasurer & Secretary James Mitarotonda - Chairman of the Board Nicholas Vlahos - Vice President and Chief Financial Officer Conference Call Participants Operator Good morning and welcome to the Eastern Company's Third Quarter Fiscal Year 2024 Earnings Call. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to your host, ...

LSI Industries, Inc. (NASDAQ:LYTS) Q1 2025 Results Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants James Galeese - Executive Vice President and Chief Financial Officer James Clark - President and Chief Executive Officer Conference Call Participants Aaron Spychalla - Craig Hallum Capital Group George Gianarikas - Canaccord Genuity Amit Dayal - H.C. Wainwright Rick Fearon - Accretive Capital Partners Operator Good day and welcome to the LSI Industries Fiscal First Quarter 2025 Result ...

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Q3 2024 Earnings Conference Call November 7, 2024 10:00 AM ET Company Participants Debbie Stewart - Chief Accounting Officer Jeff Shaner - Chief Executive Officer Matt Buckhalter - Chief Financial Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Grayson McAlister - Truist Securities Operator Good morning, and welcome to the Aveanna Healthcare Holdings Third Quarter 2024 Earnings C ...

Bridge Investment Group Holdings Inc. (NYSE:BRDG) Q3 2024 Earnings Conference Call November 7, 2024 9:30 AM ET Company Participants Bonni Rosen - Head, Shareholder Relations Robert Morse - Executive Chairman Jonathan Slager - Chief Executive Officer Katie Elsnab - Chief Financial Officer Dean Allara - Vice Chairman Conference Call Participants Mike Brown - Wells Fargo Securities Ken Worthington - JPMorgan Michael Cyprys - Morgan Stanley Operator Thank you for standing by. My name is Mark and I will be your ...

Credicorp Ltd. (NYSE:BAP) Q3 2024 Results Conference Call November 8, 2024 9:30 AM ET Company Participants Milagros Cigüeñas - Investor Relations Gianfranco Ferrari - Chief Executive Officer Alejandro Perez-Reyes - Chief Financial Officer Francesca Raffo - Chief Innovation Officer Cesar Rios - Chief Risk Officer Carlos Sotelo - Mibanco's Chief Financial Officer Conference Call Participants Ernesto Gabilondo - Bank of America Renato Meloni - Autonomous Research Tito Labarta - Goldman Sachs Thiago Batista - U ...